Skip to main content
logo
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.71
+0.79 (10.05%)
Sep 17, 2026, 11:33 AM EDT - Market open

ImmunityBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9,2261,9501,8693,3522,0762,419
Market Cap Growth
256.21%4.33%-44.23%61.49%-14.18%-
Enterprise Value
10,0972,5522,7593,8822,6762,681
Last Close Price
7.911.982.565.025.076.08

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
55.5217.22126.775388.888648.472589.53
PB Ratio
--3.90-3.83-5.72-4.61-9.92

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
60.7722.53187.096241.2011149.272870.55

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.17-1.69-1.62-1.51-1.61-2.66
Net Debt / Equity Ratio
-0.83-1.20-1.31-1.05-1.37-1.35
Net Debt / EBITDA Ratio
-3.70-2.50-1.96-1.80-1.86-1.09
Net Debt / FCF Ratio
-3.02-1.95-1.61-1.55-1.48-1.07
Asset Turnover
0.320.260.030.000.000.00
Inventory Turnover
0.260.16----
Quick Ratio
5.364.622.784.630.220.86
Current Ratio
5.725.103.365.050.280.91
Return on Assets (ROA)
-30.54%-36.17%-48.48%-52.11%-52.73%-57.48%
Return on Capital Employed (ROCE)
-45.60%-58.20%-104.90%-81.00%253.20%-317.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.78%-18.02%-22.13%-17.40%-20.07%-14.34%
FCF Yield
-3.13%-15.83%-21.30%-11.85%-20.03%-12.73%
Buyback Yield / Dilution
-26.61%-31.33%-37.71%-27.19%-2.74%-3.23%
SEC Filings: 10-K · 10-Q